Several reports have investigated the involvement of adipokines in breast cancer progression and recurrence, also highlighting the important role of adiponectin in obesity-related breast cancer [28,29,30,37,38,39,40,54]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.